Bone Morphogenic Protein 2 (BMP2) can induce ectopic bone. This ability, which first motivated the widespread application of BMP2 in fracture healing and spinal arthrodesis has, more recently, been indicated as one of several serious adverse effects associated with the supra-physiological doses of BMP2 relied upon for clinical efficacy. Key to harnessing BMPs and other agents safely and effectively will be the ability to localize activity at a target site at substantially reduced doses. Clay (Laponite) nanoparticles can self assemble into gels under physiological conditions and bind growth factors for enhanced and localized efficacy. Here we show the ability to localize and enhance the activity of BMP2 to achieve ectopic bone formation at doses within the sub-microgram per ml range of concentrations sufficient to induce differentiation of responsive cell populations in vitro and at approximately 3000 fold lower than those employed in clinical practice.

Bone induction at physiological doses of BMP through localization by clay nanoparticle gels / D.M.R. Gibbs, C.R.M. Black, G. Hulsart-Billstrom, P. Shi, E. Scarpa, R.O.C. Oreffo, J.I. Dawson. - In: BIOMATERIALS. - ISSN 0142-9612. - 99:(2016 Aug), pp. 16-23. [10.1016/j.biomaterials.2016.05.010]

Bone induction at physiological doses of BMP through localization by clay nanoparticle gels

E. Scarpa;
2016

Abstract

Bone Morphogenic Protein 2 (BMP2) can induce ectopic bone. This ability, which first motivated the widespread application of BMP2 in fracture healing and spinal arthrodesis has, more recently, been indicated as one of several serious adverse effects associated with the supra-physiological doses of BMP2 relied upon for clinical efficacy. Key to harnessing BMPs and other agents safely and effectively will be the ability to localize activity at a target site at substantially reduced doses. Clay (Laponite) nanoparticles can self assemble into gels under physiological conditions and bind growth factors for enhanced and localized efficacy. Here we show the ability to localize and enhance the activity of BMP2 to achieve ectopic bone formation at doses within the sub-microgram per ml range of concentrations sufficient to induce differentiation of responsive cell populations in vitro and at approximately 3000 fold lower than those employed in clinical practice.
Bone induction; Bone morphogenic protein; Clay gels; Drug delivery; Hydrogels; Smectites
Settore BIO/11 - Biologia Molecolare
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
Settore BIO/14 - Farmacologia
Settore BIO/13 - Biologia Applicata
ago-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0142961216301776-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.91 MB
Formato Adobe PDF
1.91 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Final%20submission%20following%20revisions%20optimised.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 5.95 MB
Formato Adobe PDF
5.95 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/964596
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 59
social impact